Review Book Flashcards

1
Q

TCR complex

A

TCR (alpha/beta or gamma/delta)
Cd3 (epsilon/delta and gamma/epsilon),
2 zeta chains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

NKT cell recognize

A

Lipids in context of Cd1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Costimulatory signal in t cell activation

A

Cd28 (T cell receptor) with B7-1 (cd80) or B7-2 (cd86)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

T cell survival signal

A

IL-2 with its receptor CD25

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cd80/86 increased/decreased by:

A

Increased by PAMPs/bacterial products detected by dendritic cells

Decreased by CTLA-4 that pushes out cd28 and binds cd80/86, downregulating it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mutation causing x-linked lymphoproliferation syndrome (XLP)

A

Mutation in SAP
SAP binds SLAM and links SLAM to Fyn (linked to cd3 proteins) on activated T cells

EBV in boys with XLP can develop HLH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Zap-70 deficiency cell enumeration

A

No Cd8 cells
No T cell function
Normal B cells
Normal NK cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

T cell activation signaling sequence

A
  1. Antigen binds TCR (via MHC)
  2. Lck phosphorylates cd3 and zeta proteins, recruiting zap-70
  3. Zap-70 phosphorylates LAT
  4. Lat becomes docking site for PLC-1 and Grp2
  5. Grp2 recruits sos that catalyzes GDP to GTP on RAS —> Mek>erk>Fos>ap-1 transcription factor
  6. PLC converts pip > DAG and ip3, activates:
    A. DAG -> PKC -> NFkB
    B. IP3 -> increased intracell Ca via CRAC on cell membrane -> calmodulin >calcinuerin > NFAT > cytokine transcription
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

BCR complex components

A

Surface immunoglobulin
Ig alpha and Ig beta chains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

BCR signaling cascade

A
  1. Lyn P itam (Igalpha/beta), docking for Syk
  2. Syk (~zap-70 analogue) P BLNK
  3. BLNK activates ras, rac, plc, btk, grb-2
  4. Btk + Syk activate PLC -> PIP2 into ip3/DAG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How complement enhances BCR

A

Antigen opsonized with c3b > degraded to c3d
C3d ligand for cd21(cr2) on B cells
Forms complex - cd21-cd19-cd81
- when binds c3d, complex goes to BCR and activates cascade with enhanced response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Inhibitory receptors in T, B, and NK cells

A

T cells - ctla-4, pd-1
B cells - fcgammaRIIbeta
NK cells - KIRs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

NFkB activators

A

IL-1, TNF, IL-17, TLR activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Antiviral Cytokines

A

Type I interferon (IFNalpha/beta), IL-28A, IL-28B, IL-29

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cellular immunity cytokines

A

IL-2, , ifn gamma, IL-15, IL-17

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Humoral immunity cytokines

A

IL-7, IL-11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Anti-inflammatory cytokines

A

TGF-beta, IL-10, il-37, il-38

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Cytokines in isotope switching

A

IL-4 and -13 — IgE
Tgf-beta, il-5 — IgA
Il-10 — igg4
IFN-g - IgG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

TNF actions

A

Acute inflammation (esp GNR)
Recruits neutrophils/monos
Stimulates endothelial cells to express adhesion molecules and induce chemotaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Lymphotoxin action

A

Activates endothelial cells and neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

BAFF action

A

Survival signals to maturing B cells
Upregulates anti-apoptotic Bcl-2 activation of NFkB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

APRIL cytokine action

A

Upregulates anti-apoptotic Bcl-2 activation of NFkB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Il-1 action at high and low concentrations

A

Low - local inflammation, endothelial cells increase surface molecules for leukocyte adhesion

High - fever, synthesis acute phase reactants in the liver, neutrophil/plt production in bone marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

IL-18 source

A

Macrophages
Dendritic cells
Pro-molecules cleaved by caspase-1
NOT made by T, B, or NK cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Il-18 actions

A
  • IFN-gamma production by T and NK cells
  • inhibits IgE synthesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

IL-33 actions

A

Alarmin (w/ TSLP, Il-25)
T cells - Th2 development
ILCs - activate group 2 ILCs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Il-37 action

A

With SMAD3 in nucleus - inhibits transcription pro-inflammatory mediators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Anakinra target

A

Binds IL-1R (IL-1Ra) to prevent Il-1 pro-inflammation in autoinflammatory syndromes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

IRAK-4 deficiency infections

A

Pyogenic infections, esp strep pneumonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Il-19 action

A

Activates monocytes to release il-6, TNF-alpha, ROS

promotes Th2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Il-22 action

A

From Th-17 cells
Epithelial cells increase defensins and barrier function

Induces MHC class I antigen expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

IL-12 actions

A
  • Stim ifn-gamma production by T and NK cells
  • promotes Th1 cells (that produce ifn-gamma)
  • increases production il-18 receptor (il-18 aka ifn-gamma inducing factor)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Il-23 actions

A
  • important in protection klebsiella PNA
  • promotes differentiation/maintenance Th17 cells (that produce il-17)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Il-27 action

A
  • Promotes Th1
  • promotes ifn-gamma production by t cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Type I ifn action
(Ifn-alpha, -beta)

A
  • inhibit viral replication
  • increase class I MHC expression
  • stimulate Th1 cells
  • promote sequestration lymphocytes in LNs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Il-7 action

A

Survival of T cells (esp cd4)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Il-21 action

A

Class switching and Ig production by B Cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

IL-2 action

A
  • required for survival/function Tregs
  • proliferation of NK cells
  • induces Bcl-2 expression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

IFN-gamma action

A
  • Promotes Th1 differentiation
  • Inhibits Th2 differentiation
  • Inhibits class switch IgE, IgG4
  • increases MHC on APCs
  • promotes macrophage inflammation and inhibits IgE-dep eosinophil rich reactions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

il-16 action

A

Promotes Th1/dampens Th2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Il-17 action

A
  • increases th17
  • increases chemokines/cytokines
  • increases gm-csf and g-csf
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Il-25 action

A

Alarmin
Increases il4, 5, 13

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Il-4 action

A
  • th2 differentiation
  • class switch to IgE and IgG4
  • it’s receptor, il-4R signals through Jak-stat (stat6)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Il-5 action

A
  • activates eos
  • B cell proliferation and IgA production
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Il-13 action

A
  • fibrosis as tissue repair of chronic inflammation
  • mucus by lung epithelial cells
  • IgE and IgG4 class switching
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Il-6 action

A
  • pro-inflammatory
  • stimulates acutely phase protein synthesis in liver
  • production neutrophils in BM
  • T cells to produce il-17
  • signaling involves jak1/stat3
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Il-15 action

A
  • survival of memory CD8 T cells, NK cells, NKT cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

TGf-beta

A
  • anti-inflammatory cytokine
  • inhibits proliferation/function T cells
  • inhibits macrophage activation
  • induces apoptosis
  • regulates tissue repair and activates fibrosis
  • uses Smad receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Gm-csf action

A

Promotes granulocytes, monocytes, macrophage activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

M-csf action

A

Promotes monocytes maturation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

G-csf action

A

Granulocyte maturation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

IL-33 action

A

Th2 development
Activates group 2 ILCs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Il-3 action

A
  • promotes mast cell development BM
  • basophil-differentiating cytokine
  • eos development
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

C-kit ligand action

A
  • mast cell growth factor
  • sustains viability T cells in thymus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Castleman’s disease

A

Overproduction Il-6
LN hyperplasia,
Fever, microcytic anemia, LAD, hypoalbuminemia, high CRP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Role of cytokines IL-1 -5

A

Hot T-Bone stEAk
Il-1 - fever
Il-2 - stimulates T cells
Il-3 stimulates bone marrow
Il-4 stimulates IgE
Il-5 stimulates IgA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

X-linked SCID receptor mutation

A

GammaC, part of IL-2R. Important for il-2r, il-4r, il-7r, il-9r, il-15r, -il-21r

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Il-2R components

A

Il-2Ralpha
Il-2R beta
GammaC
Engages jak3-stat5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Source of chemokines

A

Epithelial cells, endothelial cells, leukocytes, fibroblasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Chemokines assoc w/ atopy

A

CCL2, CCL5, ccl7, ccl11
Cxcl8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

WHIM syndrome

A

Warts
Hypogamm
Infections
Myelokathexis (retention neutrophils in BM)

Assoc w/ defects in CXCR4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

CC chemokines

A

Recruits eos, monos, basos
Lymphocytes for ALLERGY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

CXC chemokines

A

Recruits Neutrophil
Lymphocytes for INFLAMMATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

Ccl5 (RANTES) receptor

A

CCR 1,3,5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

CCL11 (eotaxin) receptor

A

CCR3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

CCL17 (TARC) receptor

A

CCR4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

CXCL8 (IL-8) receptor

A

CXCR 1,2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

Selectins role

A

Rolling of leukocytes and binding carbs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

P-selectin summary

A

Aka CS62P
On Platelets,
ligand PGSL (and sialyl-lewis),
binds Pmns, T cells, monocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

E selectin summary

A

Aka CD62E and ELAM
On Endothelium
Binds ESL-1, cd15, pgsl, sialyl lewis
Homes T cells to sites inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

L selectin

A

Aka LAM-1, CD62L
On Lymphocytes Leukocytes
Ligands gLycsm-1, madcam-1, cd34, Sialyk-lewis
Homes to LN HEV (via Glycam) and PMN rolling (via madcam)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

LAD-2 deficiency and selectins

A

PMNs can’t express carb ligands for E and P selectin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

Role beta integrin family (alpha4beta7)

A

Gut homing
Binds madcam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

Chemokine in heparin induced thrombocytopenia

A

Cxcl4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

HIV chemokinea

A

CCR5
if homozygous mutation - no HIV infection
If heterozygous - slow infection progression

CXCR4

CCL3L1
- if low level, higher HIV acquisition and worse disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

Atherosclerosis chemokine

A

CXC3CL1

CX3CR1
- v249I mutation —> increased risk acs
- T280M —> protects against plaque

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

Glanzmann’s thrombasthenia chemokine

A

GIIbIIIa defect leads to plt defect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

Alternative pathway C3 convertase

A

C3bBb

Stabilized by properidin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

Alternative pathway activation

A

C3 tick-over to C3b in microbial surfaces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

Only known positive regulator of complement system

A

Properidin
Stabilizes factor B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

Classical pathway activation

A

Antigen-Ab complex binds C1
(Binds CH2 domain IgG or CH3 of IgM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

Classical pathway c3 convertase

A

C4b2a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

Binding affinity order of c1q for immunoglobulin

A

IgM > IgG3 > IgG1 > IgG2

Cannot bind IgG4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

Involved pathway if love C3 and C4

A

Classical pathway activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

Lectin pathway activation

A

MBL binds mannose on microbial polysaccharides and MBL-assoc protease 1 (MASP-1, and MASP-2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

Lectin pathway enzyme that cleaves to create c3 convertase

A

MASp-2 cleaves c4 and c2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

Lectin pathway convertase

A

C4bC2a
(Same as classical)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

C5 convertase

A

C3bBbC3b in AP
C4b2aC3b in CP and LP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

MAC

A

C5b-c8 polyC9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

Inhibitors of MAC formation on complement cascade

A

S protein and CD59

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

Complement anaphylotoxins

A

C5a
C4a
C3a
Induce inflammation and vascular permeability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

C5a role

A

Most potent mediator basophil and citaneois mast cell degranulation
(>c3a>c4a)

Chemoattractant

C3a chemotactic for eos only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

CR2 (cd21) role in complement

A

Binds c3d and is a 2nd signal for B cell activation
Decreases antigen any needed for B cell activation.
Hemos trap ag-ab complexes in germinal centers

Receptor for EBV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

Complement receptor CR1(cd35)

A

Binds c3b, c4b
Regulates c3 convertase dissociation
Phagocytosis of c3b and c4b coated particles
Clears immune complexes (cr1 on RBCs)

HIV uses to infect monocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

Complement receptor cr2 (cd21)

A

Binds c3d
Keeps ag-an complexes in terminal centers for B cell activation

EBV uses to facilitate cell entry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

Complement receptor cr3 (cd11b/cd18)

A

Binds iC3b, Icam-1
Phagocytosis and leukocyte adhesion to endothelial cells

LAD 1

Mediates phagocytosis M tuberculosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

Complement receptor cr4 (cd11c/cd18, gp150/95)

A

Bjnds iC3b
Phagocytosis
Lad type 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

Cd46 (mcp)

A

Cofactor to factor I, inactivated C3b and C4b

Assoc w/ aHUS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

CD55 (DAF)

A

Binds c3b c4b
Prevents Bb binding c3b
Prevents 2b binding c4b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

CD59

A

Prevents c9 binding C5b-8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

C3 nephritic factor

A

Autoantibodies that stabilize c3bBb
Consumption of c3

Assoc w/ c3 glomeruloneohropathy and partial lipodystrophy
- subendothelial deposits Ig and C3

Lipodystrophy - adipose source of factor D, completes formation c3bBb

(Lipodystrophy affects waist up, where more adipocytes)

Clue - low c3/nml c4 (alternative pathway)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

Anti-c1q autoantibodies

A

Auto ab to c1q
In hypocomplementemic urticarial vasculitis (huvs)
Immune complex deposition skin, joints, kidneys, lungs
Tx = hydroxychloroquine, dapsone steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

Infxn assoc w/ terminal
Complement deficiency

A

Neisseria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
104
Q

Issues w/ early classical complement pathway deficiency

A

Encapsulated orgs (strep pneumonia!)
Lupus
Accelerated atherosclerosis
(Early mi second cause death)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
105
Q

Deficiency if:
Ch50 absent
Ah50 ok

A

Low C1q, c1q, c1q, c2, c4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
106
Q

Deficiency if
Ch50 nml
Ah50 absent

A

Low factor D, factor b, properidin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
107
Q

Deficiency if
Ch50 absent
Ah50 absent

A

Low c3, c5-c9

If c3 absent —> low factor H or I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
108
Q

Complement deficiency in sle

A

C1q&raquo_space;>
Also see low c1/s, c4, c2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
109
Q

MBL deficiency infxns

A

Pyogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
110
Q

Demographic c9 and c2 deficiencies

A

C9: 1/1000 Japanese
C2: 1/10,000 caucasian

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
111
Q

Complement deficiency assoc w/ age related macular degeneration

A

Factor H

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
112
Q

Inhibitor factor XIIa

A

C1 inhibitor
Therefore inhibits kallikrein production and bradykinin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
113
Q

Factor XIIa inhibitor

A

C1 inhibitor, therefore decrease kallikrein and bradykinin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
114
Q

Factor XIIa inhibitor

A

C1 inhibitor, therefore decrease kallikrein and bradykinin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
115
Q

Type II hypersensitivity examples

A

Cell antigens
Hemolytic anemia
Good pastures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
116
Q

Type III hypersens examples

A

Sle
GN
Serum sickness
Arthur’s rxn

Immune complexes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
117
Q

Mediators type II hypersens

A

IgG and IgM
+ complement/phagocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
118
Q

3 mechanisms type II hypersensitivities

A

1- opsonization (IgG) and phagocytosis (FcepsilonRI) (eg hemolytic anemia)
2 - complement activation (eg goodpasture) - IgG/M activate classical complement
Anti-basement membrane
3 - abnormal response w/o injury (MG, Graves)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
119
Q

Arthus rxn

A

Local vasculitis from immune complexes deposition (type III hypersens)
Local edema, neutrophil infiltration, hemorrhage, necrosis
Peak intensity 4-10hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
120
Q

Serum sickness rxn

A

Type iii hypersens
Rash, joint swelling, LAD, fever
7-12d after trigger start

Kidneys, liver, hemolysis

Re-exposure, sx onset 12-36 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
121
Q

Type iii hypersens

A

Immune complex deposition
- vasculitis
- sle
- GN
- serum sickness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
122
Q

Type iv hypersens (cell-mediated)

A

Iva - cd4 th1 (ifn-gamma), TNF a, il2); macrophages, NK cells — contact dermatitis, TB

IVb - cd4 Th2 — eos, B cells — DRESS, morbillifirm drug rash

IVc — cd8, perforin, granzyme — psoriasis, drug induced Hep B

IVd — T cells — neutrophils — contact derm, agep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
123
Q

2 types NK cells

A

Cd56bright - 10%, cytokine producing
Cd56dim - 80%, activated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
124
Q

Antimicrobial peptide examples

A

Cathelicidins
Defensins
Produced by keratinocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
125
Q

Cytokines released from neutrophils

A

Il-1a, Il-12, -23, APRIL, BAFF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
126
Q

Cytokines from monocytes

A

TNF-alpha, Il-1, Il-6, Il-8, il-12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
127
Q

Dendritic cell cytokines

A

Il-1, il-6, il-23, TNF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
128
Q

Eosinophil proteins

A

Major basic protein
Eosinophil cationic protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
129
Q

Mast cell cytokines

A

Ifn gamma, il6, TNF alpha, tgf beta, PAF, tryotase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
130
Q

Basophil cytokines

A

Il-4, il-6, BAFF, tslp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
131
Q

NK cell cytokines

A

TNF alpha, il-10, ifn-gamma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
132
Q

DAMPs

A

Damage associated molecular patterns
Endogenous molecules released by injured cells (NOT from apoptosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
133
Q

PRR (patent recognition receptors)

A

In APCs
Recognize DAMPs and PAMPs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
134
Q

Cytokines that require cleavage by inflammasome to be activated

A

Il-1 and Il-18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
135
Q

TLR ligands

A

PAMPs
Activate innate immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
136
Q

TLR that recognizes RSV and rhinovirus

A

TLR 2, 6, 7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
137
Q

TLR 4 ligands

A

GNR (lipopolysaccharides) , GP bacteria (peptidoglycans), rsv, acute phase proteins (Hsp 70, 90)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
138
Q

Adaptor protein involved in all TLR signaling (except TLR3)

A

MyD88

Activates NFkB and AP-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
139
Q

TLR3 signaling mediators

A

TRIF, TRAF

Activates IRF3 and IRF7, induce type I IFN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
140
Q

Endosomal TLRs

A

Live in a NEST
Nine
Eight
Seven
Three

Play big role in viral recognition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
141
Q

TLR affected with hav encephalitis

A

TLR3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
142
Q

TLR pathway with Pyogenic infections

A

MyD88, IRAK4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
143
Q

NEMO deficiency

A

Canonical incisors, ectodermal dysplasia, recurrent bacterial infections
IKKgamma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
144
Q

Chronic mucocutaneous candidiasis deficiency

A

CARD9 - (cascade activation and recruitment domain), part of inflammasome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
145
Q

Cryoporin associated periodic syndromes (caps) mutation

A

NLRP3 - inflammasome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
146
Q

Central tolerance T cells

A

Via AIRE in MTEC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
147
Q

B cell central tolerance (negative selection)

A

Receptor editing with help RAG1/2 and light chain rearrangement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
148
Q

Thymus develops from which branchial arch

A

3 and 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
149
Q

T cell positive selection

A

If bind strongly enough to peptides bound by MHC on cortical Thu if epithelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
150
Q

T cell negative selection

A

AIRE induces expression self antígena
Occurs in medulla
(Negative selection in cortex)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
151
Q

When do T cell lose double positivity (cd4+cd8+)

A

When leave cortex and go to medulla

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
152
Q

How do naive T cells home to parafillocular zone in T cells

A

Their CCR7 (on mature naive T cells) binds ccl19/21 from dendritic cells/stromal cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
153
Q

How do T cells leave LN?

A

Via S1P gradient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
154
Q

What do Gamma delta T cells recognize

A

Lipids and heat shock proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
155
Q

Where are Gamma delta T cells found?

A

Gut tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
156
Q

NK T cell recognize and produce?

A

Recognize glycolipids

Produce ifn gamma, IL-4, -3, -17

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
157
Q

What cytokines induce, are produced by, transcription factors of Th1

A

Induced by il12, ifn gamma
Produce ifn gamma
Txn factor Tbet, stat4
For intracellular defense

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
158
Q

What cytokines induce, are produced by, transcription factors of Th2

A

Induced by il4,
Produce il4, 5, 13
Txn factors gata3, stat6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
159
Q

What cytokines induce, are produced by, transcription factors of Th17

A

Induced by il-6
Produces il-17,
Txn factor RORgammaT, stat3
Extracellular defense
Psoriasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
160
Q

What cytokines induce, are produced by, transcription factors of Th9

A

Induced by tgf beta
Produces il9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
161
Q

What cytokines induce, are produced by, transcription factors of Tfh

A

Induced by/produces il-21
Txn factor bcl-6
Helps B cells make antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
162
Q

What cytokines induce, are produced by, transcription factors of Tregs

A

Induced by tgf-beta
Produces tgf-beta, Il-10
Txn foxp3, stat5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
163
Q

3 types Treg

A

Natural T regs in thymus - mediate self tolerance
Induced Treg (Tr1) in periphery - suppress effector cells
iTreg (Th3) - in periphery, help IgA production in gut

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
164
Q

Where are B cells first produced in fetus

A

Fetal liver @7eks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
165
Q

How mature naive B cells enter LN

A

Express cxcl5 that binds cxcl13 expressed by follicular dendritic cells i

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
166
Q

How follicular naive B cells in LN follicles move to border with T cells

A

Activated by antigen presenting dendritic cells, increase ccr7 expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
167
Q

Which interaction needed to stimulate B cell switch recombination (class switching)

A

Cd40 (b cell) with cd40L (follicular helper T cell)

Also need AID and UNG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
168
Q

HyperIgM causes

A

Deficiencies in cd40, cd40L, AID, UNG

Ig gets stuck in IgM form (doesn’t have tools for class switching

CD40L on T cells affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
169
Q

Somatic hypermutation (affinity maturation)

A

T cell dep (need cd40-cd40L)
In germinal center
Point mutations in V regions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
170
Q

Peripheral B cell survival signals

A

BLYSS, APRIL, BAFF

receptors on B cells are BR3, TACI, BCMA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
171
Q

Role of Tdt
Terminal deoxynucleotidyl transferase

A

Adds nucleotides randomly during vdj recombination At hairpins

Responsible for heterogeneity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
172
Q

B 1 B cells

A

In peritoneal cavity and fetus

Independent of T cells

Doesn’t need antigen - constitutive secrete Ig

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
173
Q

What has vdj recombination

A

Ig Heavy chains and TCR beta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
174
Q

12/23 rule

A

In vdj recombination, a gene segment flanked by 12 nt spacer can only be joined by gene segment flanked by 23 nt spacer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
175
Q

RSS

A

Recombination signal sequences
12 or 23nt long

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
176
Q

Role rag1/2

A

Align 2 RSSs
Cleave dsDNA between coding segment and RSS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
177
Q

Artemis

A

Opens hairpins at coding ends (with DNA-pk
Vdj rearrangement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
178
Q

DNA ligase IV /XRCC4

A

Ligate coding and rss joints

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
179
Q

Lymphocyte pro-apoptotic proteins

A

Intrinsic - Bim binds Bax and bak to activate caspase 9

Extrinsic - FasL binds Fas, activates caspase 8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
180
Q

Lymphocyte apoptosis pathways converge on ___ to lead to apoptosis

A

Caspase 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
181
Q

Cytokines that stimulate NK cells

A

Ifn alpha, beta, il12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
182
Q

Cytokine needed for NK cell development

A

IL15

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
183
Q

ILC in allergy

A

Ilc2 recruited to lung and skin after allergen, il5 dep eos recruitment, il13 smooth m contraction, mhc II th2 enhancement —> allergy and fibrosis

ILC3s -> increased in BAL of asthmatics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
184
Q

FCepsilonRI is expressed on 2/3:
Mast cells
Basophils
Eosinophils

A

Not on eosinophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
185
Q

Cytokines stimulating differentiation of mast cells, basos, eos

A

Stem cell factor - mast cells
Il-3 to basos
Il-5 to eos

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
186
Q

Mast cell progenitors and where develop

A

Ckit+ (cd117), cd34+ stem cells
Develop after arrival in tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
187
Q

Progression of mast cell mediator release

A

<15 mins - preformed mediators (tryptase, histamine, heparin, chymase)

10-30mins - lipid mediators (PGD2, LTC4, LTB, paf)

Hrs-days - cytokines and chemokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
188
Q

FCeRI binding IgE

A

Mast cell activation
Alpha, beta, and 2 gamma chains

IgE binds via alpha chain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
189
Q

Peak IgE in relation to pollen season

A

4-6wks after peak pollen season

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
190
Q

Immunodeficiency with high IgE

A

Bullous pemphigoid
WAS
Omenn
IPEX
Atypical incomplete DiGeorge
Netherton

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
191
Q

MRGPRX2 receptor

A

Susceptible mast cells activated by this receptor with certain medications - cipro, atracurium, vanco, narcotics (except fentanyl)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
192
Q

Basophil receptor

A

CD123 (il-3 receptor)
Il-3 important for expansion/differentiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
193
Q

Eosinophils preformed mediators

A

Mbp, eos cationic protein, eos peroxidase, eos-derived neurotoxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
194
Q

Markers on eos (flow cytometry)

A

Siglec-8, CCR3, EMRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
195
Q

Eos Txn factor

A

GATA1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
196
Q

Chemokines that draw eos to tissues

A

RANTES (ccl-5) and eotaxin (eot-1/ccl11 and eotaxin-2/ccl24)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
197
Q

Eosinophilia level

A

> 500 cells/ul

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
198
Q

Eosinophilia ID ddx

A

Hyper-IgE
Omenn
IPEX
Zap70 def
Netherton synd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
199
Q

Most common cause eosinophilia in US worldwide

A

US - drug reactions
WW - parasites (NOT protozoa - giardia, amoeba)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
200
Q

Eos suppressed by

A

Fever, steroids, most viral/bacterial infxn (HIV raises eos)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
201
Q

Hyper eosinphilic syn criteria

A

eos >1500 x2 at least 4 wks apart
AND
end-organ damage OR tissue involvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
202
Q

Causes eosinophilia

A

NIAAA
Neoplasm
Infection
Allergic
Autoimmune
Adrenal insufficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
203
Q

Monocyte surface marker

A

CD14 (part of TLR4 and a LPS receptor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
204
Q

Macrophage surface molecules

A

CD14, CD16, CD11b/CD18, CD33

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
205
Q

Macrophage activation

A

Classical M1: Induced by LPS or Th1 cytokines (IFN-gamma), phagocytose and present antigen, secrete Th1 cytokines (TNFa, IL6, IL1beta _> T cell activation

Alternative M2: induced by steroids and Th2 cytokines, reponse to parasitic infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
206
Q

Macrophage activation syndrome/HLH

A

uncontrolled activation macrophages with increased cytokines. Predisposing ID and low NK cells + immune activation –> damage

High fever, HSM, high ferritin and TG, low fibrinogen, hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
207
Q

HLH dx criteria

A

> /5 of the following:
fever splenomegaly
cytopenia in 2+ lines, hyperTG
hypofibrinogenemia hemophagocytosis
low/absent NK cels ferritin <500
soluble CD25 >2400 (activated T cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
208
Q

Plasmacytoid dendiritic cells

A

Marker CD123, secrete IFNa and are in viral infxn
(unique dendritic cell subset, as no CD11c expression)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
209
Q

Langerhans cells

A

dendritic cell subset, marker CD11c, Birbeck granules
Prime CD8 T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
210
Q

Dendritic cell maturation

A

Immature in the tissue, where uptake antigen
Mature in lymphoid organ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
211
Q

CD1 isoforms

A

class I MHC like molecules that present nonpeptide molecules to T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
212
Q

Langerhans cell histiocytosis markers

A

Confirm LC identity on bx with CD1a and CD207

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
213
Q

chemokines attracting neutrophils in tissue

A

IL-8 (CXCL8), LTB4
Also with sialyl-lewis, e-/p-selectings, LFA1/ICAL1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
214
Q

Color of basos, eos, neutrophils on H&E stain

A

Basos - basic blue
Eos acidic, bright red
Neutrophils neutral pink

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
215
Q

ELANE mutation

A

affects CD11b in granulocyte elastase in neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
216
Q

Neutrophil granules

A

primary - MPO, defensins, cathelicidin/cathepsin

Secondary - lysozyme, collagenase, elastase, lactoferrin, Cd11b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
217
Q

Chediak Higashi neutrophil granule change

A

Enlarged primary granules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
218
Q

heparin induced thrombocytopenia antibodies

A

against plt antigen PF4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
219
Q

WAS

A

eczema, infections, thrombocytopenia
defective WASp gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
220
Q

Steroid resistant asthma role smooth muscle

A

Airway smooth muscle unregulates glucocorticoid receptor (GR)-beta, a negative inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
221
Q

Required for B and T cell development

A

IL-7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
222
Q

B cell negative selection

A

Auto reactive/nonfunctional B cells removed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
223
Q

Parts of thymus

A

Subcapsular zone - lymphocyte progenitors

Cortex - lymphocytes in division, expression, TCR section
- positive selection with TCR re-arrangement compatible with MHC
- negative selection begins in cortex - auto reactive/nonfunctional T cells/TCRs apoptose

Medulla - where final stages selection/maturation
- most of negative selection
- has Hassles corpuscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
224
Q

Cryopatches

A

T cell precursors that go to cryopatches instead of thymus - lymphoid aggregates under intestinal
epithelium to form specialized T cell populations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
225
Q

2 follicle types in LNs

A

Primary - site resting B cells
Secondary - germinal center of B cell proliferation

Ratio primary to secondary LNs defines LN activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
226
Q

Area of spleen where lymphocytes are

A

White pulp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
227
Q

Which cells only undergo negative selection

A

B cells

T cells undergo positive and negative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
228
Q

Nasal airway resistance regulated by

A

Nasal valve, which is controlled by swelling inferior turbinate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
229
Q

Sinus development

A

Maxillary/ethmoid present at birth
Sphenoid develop at 3yo
Frontal at 6yo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
230
Q

Sinuses listen to
FM AM PS SS

A

Frontal, maxillary, ant ethmoid drain into middle meatus

Posterior ethmoid, sphenoid drain into sphenoethmoidal recess above superior turbinate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
231
Q

Lower airway changes asthma vs copd

A

Asthma: smooth m enlarged in LARGE airways, have increased cd4 and eos, increased il-5/4,

Copd: enlarged smooth m in SMALL airways, increased acidic glycoproteins, cd8, NO increased il5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
232
Q

Mast cells in dermis express

A

Cd68

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
233
Q

Homing cells to skin via

A

CCR4/ccl17 and ccr10/ccl27

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
234
Q

Pemphigus vulgaris ab

A

IgG ab to desmoglein 1/3

Blisters flacid - erupt

IgG and C3 staining on suprabasal layers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
235
Q

Bullous pemphigoid

A

Tense
Prominent pruritus
IgG BP180, bp230
Linear basement membrane IgG and C3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
236
Q

Dermatitis herpetiformis

A

Small bullae elbows/knees
Pruritic
Assoc w celiac
IgA to epidermal transglutaminase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
237
Q

Fpies lab value acute episode

A

Increase neutrophils, elevated methemoglobin

Friable mucosal with villous atrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
238
Q

EOE cytokines

A

Il-5, eotaxin -3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
239
Q

Labs to diagnose celiac

A

Gliadon sensitivity
Anti-tTG IgA (tissue transglutaminase)

Total IgA (if IgA deficient, false neg anti-ttg iga

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
240
Q

Study type and statistic

A

Cross-sectional - prevalence
Case-control - odds ratio
Cohort (subjects with common characteristic - who develops dz) - relative risk
Rct - absolute risk reduction, suggest causality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
241
Q

Type I (alpha) error

A

Falsely reject null hypothesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
242
Q

Type II (beta) error

A

Falsely accept null (commonly from underpowered studies)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
243
Q

Odds ratio

A

Axd/ b x c

(True pos x true neg) / (false pos x false neg)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
244
Q

Relativ risk

A

Incidence in exposed / inc unexposed

Ppv / c/ c+d

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
245
Q

Absolute risk

A

Number events in treated or control group / number people in the group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
246
Q

Elements informed consent

A

Competence, disclosure, understanding, voluntariness, consent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
247
Q

Risk factors allergic rhinitis

A

FHx atopy
IgE > 100 before age 6
Increased SES
Maternal smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
248
Q

Immediate allergic response
Sx and their mediators

A

Histamine - itch, sneeze, rhinorrhea
PGD2 and leukotrienes - nasal congestion
Kinins- nasal congestion/blockage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
249
Q

Priming

A

Chronic inflammation leads to lower dose of allergen to elicit sx (AR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
250
Q

First line tx perennial and seasonal AR

A

Perennial - intranasal steroids
Seasonal - inteanasal antihistamines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
251
Q

Most effective med rhinorrhea

A

Jntranasal ipratropium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
252
Q

NARES

A

No allergic rhinitis w eosinophils

Eos>20% on nasal smear
Middle aged men
Yr-rnd sx
Abnml PG metabolism
Tx - topical steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
253
Q

Gustatory rhinitis nerves

A

Stimulation sensory c-fibers
Parasympathetic reflex,
Chokinergic muscarinic receptors
Tx - ipratropium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
254
Q

Atrophic rhinitis

A

Noninflammatory
Progressive atrophy in middle aged men in warm countries (Saudi Arabia)
Klebsiella colonization
Foul smell nasal vault

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
255
Q

Secondary atrophic rhinitis

A

Causes: multiple ess empty nose syndrome
granulomatous disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
256
Q

Rhinitis of pregnancy Tx

A

Intranasal corticosteroids are ineffective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
257
Q

AFRS

A

Eosinophilic process (mbp, Il-5, etc)
Asymmetric?
Peanut butter mucus (brown and viscous)
Ct - central hypoattenuation
Bony demineralization
MRI - hyper intense areas in mucin (heavy metals iron mgn within mucin) - heterogenous opaciticTikn)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
258
Q

AFRS criteria

A

All 5:
1. Hypersens to fungi confirmed
- asp., alternaría, curvularia, penicillium, fusarium, bipolaris
2. Nasal polyposis
3. Ct findings
4. Noninvasive fungus in mucin or in cx
5. Eosinophil mucin w/o invasión into sinus tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
259
Q

Vernal conjunctivitis

A

Sight threatening
chronic conjunctiva inflammation
Young males in warm dry climates
Severe photophobia, intense itching
Worse with antihistamines (increased dryness)
+verna;/spring sx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
260
Q

Atopic keratoconjunctivitis

A

Sight threatening
Commonly with a topic dermatitis
Keratoconus
Anterior subcapsular cataracts
Gritty photophobia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
261
Q

Giant papillary conjunctivitis

A

From contacts
mechanical trauma - protein buildup on lenses - allergic reaction
Get redness, itching after contact removal, morning mucus discharge
Tx - remove contacts and use artificial tears

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
262
Q

Hordoleum versus chalazion

A

Hordoleum (stye) = pain
Chalazion = not painful

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
263
Q

Granulomatosis with polyangiitis eye findings

A

50% ocular sx
Conjunctivitis, corneal ulcers, pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
264
Q

Adult with new onset ad

A

Be concerned about cutaneous T cell lymphoma (ctcl)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
265
Q

Itch cytokine

A

Il-31
Induced by staph a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
266
Q

Cytokines reflective of AD severity

A

Cutaneous t-cell attracting chemokine (CTACK and ccl27)
Thymus and activation regulated Chemokine (TARC)

267
Q

Cytokines in acute and chronic AD

A

Acute - IL-4, -13 — th2, also il25 and -33
Chronic - Il-5, Il-12, ifn-g
Il-17, -22
“Education is chronic starting at 5 through Grade 12
— th1

268
Q

AD cell staining

A

Cd3, cd4, cd45ro,
Activated eos
Increased RANTES and TSLP
decreased antimicrobial peptides

269
Q

Lanngerhans cells

A

FcepsilonR1 lack classic beta chain
Have Birbeck granules

270
Q

Mucus plugs

A

Composed of serum, proteins, inflammatory cells, mucus and cellular debris

271
Q

Asthma predictive index
Risk school- aged asthma

A

> /4 wheeze episodes past yr PLUS

1 major
- parent w/ asthma
- AD
- aeroallergens

OR 2 minor
- food sensitivity
- peripheral eos (>/4%)
- wheeze not related to infection

272
Q

Aeroallergen sensitization to which is assoc w/ asthma pathogenesis

A

Cat, DM, cockroach, Alternaria

273
Q

Post-bronchodilator response in asthmatics

A

Increase in fev1 and/or fvc > 12%

274
Q

Methacholine challenge

A

PC <4 mg/ml diagnostic 4-16 suggestive

275
Q

FeNo increasers/decreasers

A

Increase
- viral uri
- allergic rhinitis
- nitrate-rich foods

Decrease foods
- caffeine
- smoking
- CF
- alcohol
- spirometry

Eos stimulate epithelial cells to produce NO

276
Q

Exercise induced bronchospasm

A

Sx onset after 10mins activity
Resolves 15-30mins after
Fev1 decrease at least 15% after exercise challenge

277
Q

Egg allergen heat stable

A

Ovomucoid, gal d 1

278
Q

Peanut allergen assoc w OAS

A

Ara h 8 (bet v 1 homologue)

279
Q

Peanut allergens assoc w severe anaphylaxis

A

Ara h 12, 13

280
Q

Soybean allergen w/ severe rxn

A

Gly m 5/6

Gly m 3/4 = bet v 1 homologues

281
Q

Wheat allergen assoc w anaphylaxis

A

Tri a 19

282
Q

Latex fruit syndrome fruits

A

Food allergies in 30-50%

BACK
banana, avocado, chestnut, kiwi

283
Q

Birch OAS allergens

A

Stone, fruits, apple, almond, hazelnut, so I’ve been some peanuts, celery, carrots, fennel, coriander

284
Q

Ragweed OAS

A

Melons, zucchini, banana

285
Q

Mugwort OAS

A

Celery, carrot, parsley, mustard, cauliflower, cabbage, garlic, onion

286
Q

Rate of food allergy outgrowth

A

Cows milk, soy, wheat, egg — 85% by age 5

Peanut - 20%

Tree nuts - 9%

287
Q

FPIES most common triggers

A

Milk, soy, rice, oat

50% outgrow after 2 yrs

288
Q

Cellular changes in FPIES

A

Increased neutrophils and Il-10, TNF-g

Decreased eos

289
Q

FPIES dx

A

1 major + 3 minor

Major:
- vomiting 1-4 hrs after w/o IgE sx

Minor
- 2nd episode when eaten again
- repetitive vomiting 1-4 hrs after eating different food
- lethargy, pallor, ed visit requiring ivf
- diarrhea, hypotn, hypothermia

290
Q

Celiac genetics

A

HLA-DQ2
HKA-DQ8

291
Q

Heiner’s syndrome

A

Recurrent PNA, pulm infiltrates, hemosiderosis,Fe def anemia, FTt
Peripheral Eosinophilia
Lung bx
Milk precipitans
Elimination diet

292
Q

Leading causes anaphylaxis children and adults

A

Children - food and venom

Adults - meds and venom

293
Q

MRGPRX2

A

Receptor on mast cells. Can be directly activated by small molecular weight drugs - NBMAs, morphine, fluiriquinolone, vanco
-> mast cell degranulation and non-IgE anaphylaxis

294
Q

Cytokines that correlate with hypotn in anaphylaxis

A

Il-6 and -10,
Tnf receptor 1
Mast cell tryptase
Histamine
C3a

295
Q

Compound that correlates with anaphylaxis severity

A

PAF

296
Q

Risk factors biphasic reactions

A

Severe initial reaction,
Multiple doses epi
Wide pulse P
Delay in epi administration
Unknown trigger

297
Q

Drugs that prolong effect epi

A

TCAs - prevent catecholamine re-uptake
MAOIs - prevent epi degradation

298
Q

Ratio total tryptase to mature

A

Total/mature > 20 —-> mastocytosis

Total/mature < 10 —-> other

299
Q

Tryptase in anaphylaxis

A

Peaks 60-90’
Falls after 5 hrs
Check 15’-3hrs after reaction

Can confirm but not r/o anaphylaxis

300
Q

Histamine peak in anaphylaxis

A

Rises w/in 5 mins, falls in 30-60’

301
Q

Histamine receptors anaphylaxis

A

H1 - coronary artery vasoconstriction, bronchial construction, GI smooth m contraction

H2 - coronary vasodilation, increased cardiac inotropy/chronotropy (rate, force)

H1 and H2 - systemic vasodilation, flushing HA

302
Q

Anaphylaxis treatment in patients on b-B

A

Epinephrine
Glucagon and IVF if not responding
- glucagon has inotropic and chronotropic effects not mediated by beta receptors

303
Q

Most common peri operative anaphylaxis cause us

A

Antibiotics
Europe - nmba

304
Q

Latex allergens

A

Hev b 1-13
Hev b 2 - bell pepper, olive
Hev b 5 - kiwi, potato, beet
Hev b 6 - avocado, banana, chestnut, sweet pepper
Hev b 7 - tomato potato
Hev b 14 - potato

5-7 most common healthcare workers

305
Q

Food-dep exercise induced anaphylaxis most common triggers

A

Celery
Wheat (omega 5 gliadin),

Avoid exercise 4-6hrs of ingesting food

306
Q

Vespid species

A

Very aggressive

Insects around garbage cans/food —> yellow jackets
Common in autumn
Most common cause of stings

Hornets sting when vibration sensed

307
Q

Hornet allergen

A

Dol m 5 - antigen 5

308
Q

Polistinae

A

Paper wasp
Narrow waist, dangling legs
Pol a

309
Q

Risk factor severe reaction to sting

A

No urticaria/angioedema

Only 50% chance if reacted to prior sting will react to subsequent sting

310
Q

VIT safety

A

50% have rxn in buildup phase
5-15% with systemic rxns
<5% require epi

311
Q

VIT efficacy

A

Reduces risk subsequent rxn to <5%

312
Q

VIT indications

A

Anaphylaxis
Can consider in large local reactions f impaired life, frequent exposures

Not indicated:
Large local rxn (4-10% risk systemic rxn)
Urticaria/angioedema

313
Q

Maintenance dose VIT

A

Adults - 100ug (can be increased to 200)
Children - 59 if
300ug for mixed vespid

Fire ants - whole body extracts

314
Q

Skeeter syndrome

A

Large local reactions to mosquitos + fever

315
Q

Chronic urticaria duration

A

At least six weeks

316
Q

Cholinergic urticaria versus exercise induced anaphylaxis

A

EIA will not react with passive heating

317
Q

Treatment of cold and local heat urticarial

A

Cold – cyproheptadine
Heat – hydroxyzine

318
Q

Urticarial vasculitis

A

Associate with a fever and or arthritis
Typically painful and leave markings

319
Q

Hypocomplementemic urticarial vasculitis syndrome (HUVS) criteria

A

Major (have both):
- urticaria > 6 months
- hypocomplementemia

AND
Minor (at least 2)
- venulitis of dermis
- arthralgia/arthritis
- mild glomerulonephritis
- uveitis/episcleritis
- recurrent abdominal pain
- positive c1q precipitan with assoc suppressed c1q

(Anti-c1q ab)

320
Q

Occupational asthma, versus reactive airway dysfunction syndrome

A

OA - latency period,
Reactive - subset OA, occurs after single high level exposure, sx w/in 24 hrs. Eg gases

321
Q

Common associations for occupational asthma

A

Carpenters/woodworkers - plicatic acid (activates complement)
roofers/insulators/painters - isocyanates
Nail salon/dental hygienists/plastics - acrylates, epoxy
Manufacturers of paint, plastic, epoxy — anhydrides

322
Q

OA dx

A

Measure pft at work and at home
Fev1< 20% after exposure suggestive
Methacholine challenge (neg test excludes OA)
Gold standard - inhalation challenge

323
Q

Three stages of hypersensitivity pneumonitis

A

Acute - hrs after exposure,
- NONproductive cough, fever, chills malaise,
- diffuse fine crackles
- cr nml

Subacute/intermittent - wks-mo
- PRODUCTIVE cough, dyspnea, fatigue, wt loss
- diffuse crackles
- ct micronodules, air trapping, mild fibrosis

Chronic - mo-yrs
- cough, dyspnea, wt loss
- digital clubbing
- ground glass, emphysema, honeycombing, fibrosis

324
Q

Farmers lung antigen

A

Thermophilic actinomycetes
In moldy hay, grain, compost

325
Q

Cigarette smoking, and hypersensitivity pneumonitis

A

Smoking decreases risk of HP

326
Q

HP labs

A

CD8 predominance (cd4:8 < 1)
Lymphocytosis>20%
Increased eos, neutrophils, mast cells, IgA/G/M
Noncaseating granulomas

Decreased fev1, fvc, dlco

327
Q

Organic dust, toxic syndrome (ODTS, pulmonary mycotoxicosis)

A

Noninfectious
Febrile illness after exposure to dust with toxin-producing fungi (grain, hay, textiles)
30-50x more common than HP
Complete recovery

328
Q

ABPA dx

A

Need sensitivity to A fumigatus (Asp f 1)
Elevated total IgE > 1000

When not responsive to abx

329
Q

ABPA flare

A

Doubling of baseline IgE

330
Q

COPD

A

FEV1/FVC < 70% after bronchodilation

331
Q

GOLD criteria COPD

A

Gold 0 (at risk): sx but nml spiro
Gold 1 (mild): fev1>/80% pred
Gold 2 (moderate): 50-80% pred fev1
Gold 3 (severe): 30-50% pred fev1
Gold 4 (v severe): fev1<30% or <50% + chronic resp failure

332
Q

Cells in copd

A

Neutrophils, macrophages, cd8 T cells

Neutrophils/macrophages destroy alveolar attachments that help keep airway open and elastic recoil

333
Q

Pan lobular emphysema

A

Copd type, assoc w alpha1 antitrypsin deficiency
- think in young non-smokers with copd

334
Q

Only disease modifying treatment and COPD

A

Smoking cessation

335
Q

Life prolonging treatments, and COPD

A

Smoking cessation, supplemental oxygen 24 hours per day and lung volume reduction surgery

336
Q

Copd vs ild

A

Copd
- decreased Fev1/fvc
- increases tlc
- increased frc
- clubbing uncommon
- wheezing

ILD
- nml/increased fev1/fvc
- decreased tlc
- decreased frc
- clubbing common
- Velcro rales

337
Q

Drug related ILD

A

Chemo - busulfan, bleomycin
Abx - nitrofurantoin, sulfa
Antiarrhythmics - amiidarone, procainamide
Immunosuppressives - mtx, cyclophosphamide, azathioprine

338
Q

IgG4-related lung dz

A

Increase IgG4 plasma cells and lesions in lung, liver, pancreas
IgG4>135
Fibrosis

339
Q

Contact hypersensitivity histology

A

Lymphocytes and spongiosis in upper dermis

340
Q

Contact testing delayed tiggers

A

Corticosteroids, nickel, neomycin, gold

341
Q

Allergic contact dermatitis vs irritant

A

Acd more pruritic, reactions increase between 1st and 2nd readings

Icd - more prevalent, more stinging, reaction almost immediate and decrease between 1st and second readings

342
Q

Mediators in contact dermatitis

A

IL1 alpha, IL1 Beta, TNF alpha, GM- CSF, IL8

343
Q

Poison ivy dermatitis

A

Toxicodendron dermatitis
To urushiol (an oleoresin)
Cross reactivity to mango peels

344
Q

Paraphenylenediamine

A

Most common cause Cd on hairdressers and henna tattoo

345
Q

4 types corticosteroid classes

A

Group A - hydrocortisone type
Group B - triamcinolone type
Group C - betamethasone tupe
Group D - hydrocortisone-17-butyrate type

346
Q

Resins in ACD

A

Epoxy - sensitizing only when not cured
Colophony - from pine trees, in cosmetics, topical meds, industrial products
Ethylenediamine dihydrochloride - in topical creams, aminophylline
Paraphenylenediamine (ppd) - from benzene, in henna

347
Q

HAE type I Vs type II

A

Type I - decreased c4, low/absent c1 inh with decreased function; 85% cases

Type ii - deceased c4 and increased/nml c1 inh that’s nonfunctional; 15% cases

348
Q

Acquired c1-inh deficiency

A

Ab to c1-inh
Assoc w nonhodgkins lymphoma

Low c4
Low c1q
C1 inhibitor low/normal
C1 inh function decreased

349
Q

T- B+ NK- SCID

A

Il2rg - gamma c def, x-linked, 50-60% of scids, cd132-

Jak3 def - AR, cd132+

350
Q

T- B+ NK+

A

IL7R - AR, 5% scids, no thymus
Cd3E - ar, no game m/delta T
Cd45 (ptprc gene) - ar, normal gamma/delta T cells, no thymus
Coronin 1a def - coro1a - normal thymus

351
Q

T-B-NK-

A

Ada def - ar, 20% scids, rachitic rosary, abnormal iliac bones, deafness

Activated rac2 def - defective hematopoietic energy metabolism

Reticular dysgenesis (ak2) - severe neutropenia, sensorineural deafness

352
Q

T- B- NK+

A

Xlf def (nhej1) - microcephaly, facial dysmorphism, radiation sensitivity

Artemis - DCLRE1C (Artemis), no microcephaly, AR

353
Q

Omenn syndrome

A

RAG1/2 mutation, can’t rearrange Ig genes
Decreased B cells
Erythroderma
Increased lymphoid tissues
HSM
Eosinophilia, increased IgE
Neonatal red rash

354
Q

HyperIgE type I
(Job synd)

A

Stat3 GOF
AD
triad: 1. recurrent skin/lung infections (a aureus, a pneumonia, H flu, C albicans)
2. Severe eczema
3. IgE >2000

Retained teeth, scoliosis
Absent Th17

355
Q

Hyper IgE type II

A

DOCK8
Severe eczema
Cutaneous viral and bacterial infxns (hpv, hsv, vzv, molluscum)
Decreased IgM, NK cells, TRECs
Increased eos, B cells, Tregs

356
Q

Hyper IgE type III

A

Tyk2
- similar to type II with disseminated BCG lymphadenitis, salmonellosis

(Tyk2 in il12 signaling to produce ifn-g)

357
Q

Cd40 ligand def
(X-linked hyper IgM)

A

X-linked recessive
Biliary tract and liver dz
No germinal centers
Cryptosporidium
Neutropenia
IgM normal or high, others decreased

Cd40 deficiency is AR

358
Q

Wiscott Aldrich synd

A

X-linked recessive,
Triad: immune def (bacterial/viral), eczema, small plts
EBV lymphoma

359
Q

WIP SYnd

A

WIPF
WAS protein absent
Thrombocytopenia

360
Q

Hyper IgE syndrome

A

STAT3 LOF
AD
cold skin abscesses, pneumatoceles
Scoliosis
Hard to differentiate from AD STAT3 GOF

361
Q

Netherton syndrome

A

SPINK5
Icchthyosis
Bamboo hair

362
Q

No B cells with enteroviral infections

A

XLA

363
Q

XLA

A

Btk gene
Sinopulm infxns, GI (enteroviruses)
No germinal centers - BTK req’d for survival
All Ig decreased
Nml T cells
Nml pro-B cells
- Boys with BTK will have monocytes, but no BTK expression in them

364
Q

AR agammaglobulinemia

A

Several forms, occur in pre-B cell stage when heavy chain recombines

365
Q

Aid and ung deficiency

A

High IgM, low IgG/IgA

366
Q

Good syndrome

A

Adult onset hypogamm, thymoma
Decreased B, T, eos, neutros, panhypogamm
Thymenctomy does not help immunodeficiency

367
Q

WHIM syndrome

A

Warts
Hypogamm
Infections
Myelokathexis (neutros retained in BM)

368
Q

Herpes encephalitis genes

A

Tlr3
Unc93b19
HSE with primary hsv infection
Usu 3-6yo
Decreased ifn-a and -b

369
Q

Ifn-g mutations

A

Complete absence = AR + affects extra cellular domain
AD = heterozygous, intracellulat domain

370
Q

Osteo w NYB mycobacteria

A

IFNgR1/2 deficiency

371
Q

C1q leading causes death

A

Infection, atherosclerosis and MI
(C1q plays role in cholesterol clearance)

372
Q

Complement mediated (atypical) HUS

A

Complement activated on epithelium

Treated with c5 blockers (eculizumab and ravilozumab)

Microangiopathic hemolytic anemia, thrombocytopenia, kidney injury

Disseminated neisserial ingections

373
Q

Receptors HIV uses to enter cells

A

CCR5 - monocytes/macrophages, acute infection
CXCR4 - T cells, advanced hiv dz

374
Q

Western blot hiv testing

A

Requires 2/3 bands present for + result:
Anti-p24, anti-gp41, anti-go160/gp

375
Q

HIV exposed infants tested

A

At birth, 2-3wks, 1-2mo, 4-6mo

376
Q

Elisa antibody hiv test

A

High sensitivity/mod specificity
Requires confirmatory
False + from multiple pregnancies, autoimmune dz, multiple blood
Transfusion

False -: window period

377
Q

Ritonavir and fluticasone

A

Ritonavir, inhibits cyp3a4 and cyp2dg,
Causing increased levels ICS (fluticasone) to systemic levels
Cause Cushing syndrome

378
Q

HLA B5701 and abacavir

A

Life threatening allergic reaction

379
Q

Immune reconstitution inflammatory syndrome

A

Decrease in clinical status 4-8wks after ART initiation
Reaction of reconstituting immune system and it’s reaction to opportunistic infection with cytokine storm

380
Q

EOE cytokines

A

IL-5, IL-13, eotaxin-3 (ccl26)
Eotaxin3 most overexpressed gene in EoE, receptor is CCR3. Chemotactic for eos

381
Q

Triggers EoE

A

Milk, wheat, egg, soy

382
Q

Dupilumab effect on EoE

A

May reverse esophageal dysmotility/dilation

383
Q

FIP1L1-PDGFRA fusion

A

Myeloproliferative variant HES
Mainly men
Higher risk cardiac cx
Increased serum B12, tryptase
Sensitive to imatinib

384
Q

T cell lymphocytic variant (L-HES)

A

Prominent skin findings (eczema, urticaria)
May progress to T cell lymphoma
- hypergamm
Elevated TARC/CCL17
Aberrant il5 producing T cells
Cd3-cd4+ T cells

385
Q

Dx criteria systemic masyocytosis

A

1 major + 1 minor or 3 minor:
Major: bx w dense infiltrates >15 mast cells
Minor:
- bx >25% mast cells with spindle shape
- c-kit mutation (kit D816V)
- expression CD2 and/or CD117+ mast cells
- tryptase >20

386
Q

Mast cell activation syndrome criteria (mast cell activation not meeting systemic mastocytosis criteria)

A

3 criteria needed:
A- typical s/s systemic mast cell activation (eg anaphylaxis)
B - involvement MC with biochemical studies (elevated baseline typtase, urinate metabolites, etc)
C- symptomatic response to mast cell stabilizers

387
Q

Ehrlichiosis

A

Lone star tick
SE, south central, mid Atlantic
Can trigger HLh
Smear showing intreukocytic morulae
Tx / tetracyclineor chloramphenicol

388
Q

Mendelian susceptibility to mycobacterial disease (msmd)

A

Mycobacterial disease clearance depends in ifn-g activating T cells

Defects in il-12/-23/ifn-g cause msmd

389
Q

Hep B marker infectivity/viral
replication

A

HBeAg

390
Q

Syphilis stages

A

Primary - painless chancre o genitals, skin, mucosa

Secondary - rash on palms/soles, condyloma lata (warts) in genitals, malaise, fever

Tertiary - cv, neuro

391
Q

Syphilis screening

A

Nontreponemal ab (vdrl, rpr) tests reactivity to antigen
followed by more specific treponemal test looking for antibodies (fta-abs, EIA)

392
Q

False positive syphilis testing

A

Pregnancy
Iv drug use
Tb, nonsyphillus treponemal, rickettsia, hiv
Endocarditis

393
Q

Treating AOM

A

Any signs in those <6mo
B/l involvement in those 6-23mo
Rest - shared decision making

First line uncomplicated - high dose amox x 10d
Other - augmentin

394
Q

Rhinosinusitis acute v subacute v chronic

A

Acute - up to 4wks
Subacute - 4-12wks
Chronic - >12 wks

395
Q

Bacterial causes ars

A

Strep pneumonia
Moraxella
H flu

396
Q

ARS dx criteria

A

2 major or 1 major +2 minor

Major:
Purulenta rhinorrhea
Nasal congestion/obstruction
Facial congestion/fullness
Facial pain/pressure
Fever
Hyposma/anosmia

Minor:
Headache
Ear ache/pressure/fullness
Bad breath
Dental oaon
Fatigue
Cough (post nasal drip)

397
Q

Treatment abrs

A

Augmentin (amox-clavulanate)
High dose augmentin for those at higher risk/higher risk areas

Alternative - fluoriquinolone/doxy
Alternative children - clinda + ceohalosporin

398
Q

Recurrent sinusitis

A

> 4 episodes/yr

399
Q

Th17 cells

A

Produce il-17, -22, and synergies with TNF-a and il-1b to enhance inflammation

Induced by il-6, tgf-b

Survival increased by il-23

Cytokines recruit neutrophils and enhance local innate response

400
Q

CREST

A

Calcinosis cutis
Raynaud’s
Esophageal dysmotility
Sclerodactyly
Telangectasia

Sx of sclerosis/crest synd

401
Q

Sjogrens ab

A

Ana, SS-A (Ro), SS-B (La)

402
Q

Progressive sclerosis and crest syndrome Ab

A

Anticentromere Ab

403
Q

Rheumatoid arthritis Ab

A

RF, anti-CCP

404
Q

RF meds

A

NSAIDs
Steroids
Dmards - mtx, sulfasalazine, hydroxychloroquine
Jak inhibitors (tofacitinib, baricitinib)
TNF-a blockers (infliximab, adalimumab)
Anti-Il-6 - tocilizumab
Ctla-4-Ig - abatacept
- ritux

405
Q

Macrophage activation syndrome (mas) and systemic JIA

A

10% of those with JIA have MAS

406
Q

Chediak Higashi synd

A

Oculocutaneous albinism
Neuro defects, infxn (cutaneous, sino-pulm) with GNR, staph, strep

Trafficking protein defect, granules in neutrophils fuse make enlarged granules, can’t move granules

407
Q

Familial HLH screening markers

A

Perforin and cd107a

408
Q

APECED

A

Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy

Chronic mucocutaneous candidiasis, recurrent thrush, dystrophic nails, endocrineopathies (DM, alopecia…)

AIRE mutation

Anti-interferon omega Ab very specific for test

409
Q

ALPS

A

Autoimmune lymphoproliferative syndrome
- AI cytopenias, LAD, HSM, lymphomas
Genes: FAS
Dx - high double neg T cell - TCR alpha/beta (CD3+CD4-CD8-), high B12, il-10

410
Q

IPEX

A

Immunodysregulation polyendocrinopathy enteropathy x-linked

Severe diarrhea, for allergy, early onset DM, cytopenias, skin lesions foxp3 (in Tregs)
AR

411
Q

Sezary syndrome

A

Older patients with chronic nonspecific dermatitis or generalized erythroderma

Need:
Erythroderma >/80% body
Clonal TCR rearrangement
Sezary count >/1000 or increased cd4 cells with loss cd26 cells

412
Q

Waldenstroms macroglobulinemia

A

High IgM
Assoc w chromosome 6 abnormalities

413
Q

Castlemans disease

A

Giant cell LN hyperplasia
Angiofollicular LN hyperplasia
HHV-8 implicated in pathogen

May have POEMS syndrome
(Polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin abnormalities)

414
Q

Acute hemolytic transfusion reactions (htr)

A

IgM and complement

415
Q

Delayed htr

A

Minor blood group antigens (eg Rh)
5-10d after transfusion
Increased LDH, indirect bili

416
Q

TRALI

A

Severe resp distress 1-4hrs after

Donor Ab directed at recipient neutrophil antigens or HLA determinants

417
Q

Warm reactive AIHA

A

IgG against RBCs

Positive DAT

418
Q

Cold reactive AIHA

A

IgM binds to I antigen on RBCs at cold temperatures, activates complement

419
Q

Evans syndrome

A

ITP + AIHA w/o underlying etiology

Assoc w PID (eg cvid, alps)

420
Q

Thrombotic microangiopathy

A

Triad: hemolytic anemia (non immune), thrombocytopenia, renal disease

421
Q

TTP clinical features

A

Adamts13 deficiency

FAT RN
fever
Anemia (microangiopathic hemolytic)
Thrombocytopenia
Renal failure
Neuro changes

422
Q

Graves dz

A

TSH receptor Ab

Assoc w autoimmune polyglandular syndrome type 2

423
Q

Hashimoto dz

A

Ab to TPO, TG, TSH receptor

Assoc w APS-2

424
Q

Membranous nephropathy

A

Most common nephrotic syndrome adults
Subepithelial Ig deposits activate complement

Thickening glomerular basement membrane

425
Q

MPGN

A

Thickening GBM

Assoc w hep c

426
Q

RPGN

A

Crescentic GN with focal necrotizing lesions

Can progress days-wks

Adults - pauci-immune
Kids - immune complex mediated more common

427
Q

Anti-glomerular basement membrane (anti-gbm) dz

A

In RPGN or part of Goodlasture’s synd (pulm-renal vasculitic syn)

Ab (IgG1 and IgG4) against alpha3 chain of type IV collagen
1/3 perinuclear antineutrophil cytoplasmic ab (pANCA) and cytoplasmic antineutrophil cytoplasmic ab (c-anca)

428
Q

Pemphigus vulgaris

A

Target desmogleins-1 and -3 and/or desmosome with IgG and C3
In EPIdermis

Life threatening

Flaccid bullae

429
Q

Bullous Pemphigoid

A

60-80yo
SUB-epidermis

Tense bullae on urticarial base
Target BPs - BP180 and BP230, hemidesmosome

Eosinophilic infiltrate and increased IgE

430
Q

Epidermokysis bullosa acquisita

A

In areas of trauma
Target type VII collagen

431
Q

Celiac dz genetics
And testing

A

HLA DQ2 and DQ8

IgA to tissue transglutaminase or endomysium

432
Q

AI hepatitis Ab types 1 and 1

A

Type 1:
Ss- or dsDNA
Smooth muscle
Actin
Soluble liver or pancreas Ag

Type 2:
Anti-liver-kidney-microsomes-1 (ALKM-1)
Liver-cytosol antigen (ALC-1 or LC1)

433
Q

Primary biliary cirrhosis

A

Middle aged women
HLA A 0201 and HLA DR8
Progressive inflammation of intrahepatic ducts —> chronic cholestasis, fibrosis, cirrhosis, failure

434
Q

Primary sclerosing cholangitis (PSC)

A

Inflammation, fibrosis, bile duct stricture
Affects Intra and extrahepatic ducts
Men>women
Genetics - HLA B8, DR3
Assoc w UC
Increased risk cholangiocarcinoma
Dx- ercp

435
Q

Autoimmune vs autoinflammatory conditions

A

Autoinflammatory - innate immune system, no autoantibodies or auto reactive T cells
- early age onset
- recurrent bouts similar in severity

Autoimmune
- later onset, have autoantibodies and auto reactive T cells, worse outbreaks over time
- activation adaptive immune system

436
Q

FMF

A

MEFV gene (codes pyrin)
- severe mutations - M694V
- Tx = daily colchicine which can decrease likelihood amyloidosis
Tonsillectomy can be curative

437
Q

TRAPS

A

Tumor necrosis factor receptor associated periodic syndromes
- AD, in TNFRSF1A gene
- febrile episodes can last weeks, periorbital swelling, conjunctivitis, pleuritis, HA
- amyloidosis
- Tx = Il 1 blockers, anakinra, steroids

438
Q

PFAPA

A

Tx steroids, tonsillectomy
Fevers last 3-6d, occur q3-8wks

439
Q

Mevalonate kinase deficiency (Hyper-IgD)

A

Mutation MVK gene - cholesterol and steroid synthesis pathway
Fevers 3-7d, painful LAD, apthous ulcers, and pain, arthritis

Flares from stress and vaccinations
Tx - steroids, anakinra prn

440
Q

Cryoporin assoc periodic syndromes (CAPS)

A

Mutations in NLRP3
3 diseases: cinca/nomid = most severe
Muckle wells - moderate
Familial cold induced autoinflammatory syndrome (FCAS) - mildest

Fever, rash, arthralgia, amyloidosis
Nomid with dysmorphism, dev delay, bony overgrowth, sensorineural hearing loss

441
Q

CAPS Tx

A

Il-1 blockade - anakinra, canakinumab

442
Q

Pyogenic sterile arthritis, pyoderma gangrenous, and acne syndrome (PAPA)

A

AD, mutation in CD2 binding protein 1– prolonged inflammasome activation

Early life arthritis
Then sterile pyoderna gangrenosum, cystic acne, Pyogenic sterile arthritis

Tx - il-1 blockade

443
Q

DIRA deficiency of IL- receptor antagonist

A

Uninhibited Il-1 activity -> skin and bone disease
skin and bone disease
Tx - anakinra (anti-il-1) replace lost protein

444
Q

Majeed syndrome

A

Lipin2 gene
Chronic recurrent multi focal osteomyelitis
Pain, fever, psoriatic appearing rash and acne
Tx - nsaids and steroids

445
Q

Blau syndrome
Juveline Systemic granulomatosis

A

Nod2 GOF - involved in nfkb activation
Triad: granulomatous poly arthritis
Uveitis
Pustular skin lesions
Later in life joint swelling and contractures

446
Q

NFkB -opathies

A

Related to ubiquitous dysregulation
Granulomas
Oral ulcers
Uveitis
Immunodeficiency

447
Q

Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome

A

Interferonopathy - mutations in proteasome system (PSMB8, PSMG2, etc).
Proteasomes clear ubq waste proteins

Sx - daily fevers, skin plaques, eyelid swelling, ftt, lipodystrophy

Autoimmunity - hemolytic anemia, hypothyroid
Tx - jak inhibitors interrupt interferón signaling, some success

448
Q

Deficiency of adenosine deaminase 2 (DADA2)

A

Mutations cecr1 - gene codes for ada2
Def -> adenosine accumulation, neutrophil activation, increased m1 macrophage polarization and inflammatory cytokine production

Fevers, lacunar strokes (before age 5), organomegaly, cytopenias, hypogamm, polyarteritis nodosa

Tx - steroids, tnf blockade, cyclophosphamide,

Def ada1 -> T-B-NK- SCID

449
Q

Amyloidosis

A

Native proteins that are misfolded and aggregate as insoluble, then accumulate and cause end organ damage

450
Q

Cryoglobulinemia

A

Immunoglobulins that undergo reversible precipitation at low temps

451
Q

Mixed cryoglobulinemia sx

A

Meltzers triad:
Purpura
Arthralgia
Weakness

452
Q

Granulomas labs

A

Macrophage secrete molecules after activation that promote granuloma formation :
ACE
calcitriol (1,25dihydroxyvitamine d3)
Osteopontin
Tnf-a

453
Q

Lofgrens syndrome

A

Self acute limited form sarcoidosis
Triad:
B/l hilar adenopatía
Erythema nodosum
Polyarthritis

454
Q

Granulomatosis with polyangitis

A

Triad sx:
Sinus involvement - ulcers, cobblestoning
Lungs - nodules, cavities lesions, pulm hemorrhage
Kidneys - focal segmental crescentic GN, pauci-immune

+/-c-anca, may have p-anca

455
Q

Egpa

A

Starts with asthma and allergic rhinitis
2- peripheral eosinophilia
3 - small vessel vasculitis dz

Eos>1500
P-anca

Tx mepolizumab
Asthma persists even after vasculitis improved
Most common cause mortality - cardiac dz

456
Q

Hyperacute rejection.

A

Pre-existing Ab
Mins-hours

457
Q

Acute cellular rejection

A

7d-3mo
CD8 T cells (type 4 hypersensitivity)

458
Q

Acute antibody mediated

A

Days-months
Antibodies trigger complement, endothelial injry, thrombosis
C4d deposition in capillaries (type II and iii hypersens)

459
Q

Chronic rejection

A

Months-yrs
T cells, cytokines
Ongoing acute rejection
Vascular smooth muscle proliferation, fibrosis, occlusion
- cd4 vasculopathy or accelerated graft atherosclerosis

460
Q

Tolerance transplanted graft

A

Via Tregs

461
Q

Engraftment neutrophils and platelets

A

Neutro- 3 consecutive days with anc>0.5x10^9 or 1 day >1x10^9

Plt - >20x10^9 in 3 consecutive days

462
Q

Gvhd cells

A

Donor t cells
Il-10, ifn-g, tnf-a

463
Q

Chronic GVH

A

Cd4 T cell mediated
B cells, Th17

Prevent with T cell depletion

Occurs >100 days (usu >6mo)

Fibrosis and scarring

464
Q

Acute gvh

A

<100 days

Cd45RO T cells

Ppx mtx, cyclosporine, tacro, steroids

Tissue injury - red angry rash, diarrhea, abd pain, weight loss

465
Q

Sos syndrome

A

Sinusoids obstruction syndrome
After transplant
Most often with hematopoietic cell transplantation
W/in 29 d transplant:
Bili >2
Hepatomegaly/RUQ pain
>2-5% wt gain from fluid retention

466
Q

Sweat test result

A

Cf unlikely sweat Cl </29
Indeterminate 30-59
Positive >/60

467
Q

Ivacaftor
Lumacaftor
Tezecaftor

A

Ivacaftor - increases probability cftr channel opening (gating)
Lumacaftor - Phe508del corrector, increases production cftr
Tezecaftor - F508del corrector facilitates delivery of cftr to cell surface

468
Q

Cockroach allergen

A

Bla g 1, 2, 4 5 6 9 11
Per a 1

469
Q

Standardized extracts

A
  1. Dust mite
  2. Short ragweed
  3. Cat
  4. Grasses - Bermuda and northern
    5 Hymenoptera

Extracts standardized by Center for Biologics Evaluation & Research/FDA

470
Q

Dose range allergen proteins in IT

A

1000-1500 AU/BAU

471
Q

Immuno increases seen in IT

A

Increase:
IgG blocking Ab (first IgG1 then IgG4)
IgA in resp secretions
Cd4+cd25+ regulatory cells (il-10, tgf-b,) and % cd8 cells
Initial increase and then decrease specific IgE
Th1 cytokines (Ifn-g, il-12)
Increased ifn-g:IL-4 ratio
Histamine2 receptor
Breg Dc4reg

472
Q

Immune decreases in IT

A

Seasonal rise specific IgE
Low affinity IgE receptor FceRII (cd23)
B cell activation markers
Basophil hyper reactivity
Recruitment eos, basos, mast cells in nose/lung
Allergen specific lymphocyte proliferation
Th2, Th17, il-2 receptor, NFkB activation, il-8 secretion

473
Q

What slows loss of potency in IT vials

A

Glycerine - inhibits proteolytic activity

474
Q

Antibacterial in IT vials

A

Phenol

475
Q

Extracts with proteolytic activity that degrade pollen

A

Mold, cockroach

Don’t mix with pollens, hdm, dander

476
Q

Effective maintenance scit dose aero allergen

A

5-20ug of major allergen

Aka 1000-4000 BAU/AU

477
Q

Maintenance dose venom

A

Single venom 100ug
Mixed vespid 300ug

478
Q

Rate of systemic rxns scit

A

0.2% of shots end in reaction
In 2% of patients
2% severe
2 fatalities/yr

479
Q

SLIT tab let options

A

5-grass pollen (Northergn grass, Kentucky blue, Timothy, orchard, perennial rye, sweet vernal)
Timothy grass
Short ragweed
HDM

480
Q

SLIT studies

A

first RCT with Ragweed
original studies from Noon & Freemen with timothy grass measuring conjunctival challenges

481
Q

Antihistamines

A

Stabilize histamine receptors in inactive state

482
Q

Antihistamine to be used in renal and liver impairment

A

renal - loratadine
Hepatic - use fexofenadine

Grapefruit juice decreases absorption antihistamines

483
Q

anithistamines with quickest onset

A

cetirizine and levocetirizine

484
Q

beta agonist
ultra long acting

A

carmoterol, indacaterol - onset action 5 hrs, last >/24
Bulkier the side chain - more selective for B2 receptro
larger size terminal amino group - protects from degradation by MAO

485
Q

B agonist adverse effects

A

tremor, tachycardia, prolonged QTc, MI, transient increased hypoxia
hyperglycemia, decreased K+ and Mg++

486
Q

beta agonist resistent

A

B16 arg/arg homozygotes - agonist receptor downregulation and resistance to SABAs

487
Q

If patient needs B-blocker, prefer cardioseelctive B-B

A

eg metoprolol, atenolol (not propranolol, etc)

488
Q

how to treat pt on B-b unresponsive to epi

A

glucagon

489
Q

cystinyl leukotrienes

A

LTC4, LTD4, LTE4
Form via 5-LO pathway, from LTA4 via LTC4 synthase

490
Q

leukotriene antagonist responses in AERD

A

1 - improved FEV1
2 - decreased rescue inhaler use
3 - decreased asthma exacerbations

491
Q

what to monitor while on zileuton or zafirleukast

A

liver function

492
Q

mast cell stabilizers action

A

Eg cromolyn, nedocromil
inhibit IgE-mediated Ca channel activation
Increased intracell Ca needed for mast cell degranulation
blocks activation neutrophils, eos, etc

493
Q

Muscarinic receptors

A

M1 - on eos in those w/ copd
M2 - inhibitory R on parasymp nerves; dysfunctional M2 causes increase ACh
M3 - primary mediator smooth m contraction in airways - concentation bronchi >trachea > alveoli >airway epithelium

ACh -> bronchoconstriction, mucus secretion, vasodilation

494
Q

ipratropium bromide use

A

asthma - decreases hospitalizations
COPD - 1st line,
also in rhinitis
Inhibits both M2 and M3 (muscarinic inhibitor/anticholinergic)
quick onset - 7.6mins to 50% maximal broncodilation

495
Q

Tiotropium

A

longer action than ipratropium - dissociates more slowly than ipra

496
Q

oral steroids cellular effects

A

Decrease T > B cells,
CD4>CD8
Upregulate CXCR4
slight decrease IgG/M
Decrease eos, basos, monos
Increase neutros (demargination)
Innate immunity spared

reverse decreased responsiveness to B agonists (increase receptors)

497
Q

STEROID side effects

A

Stunt growth, Subcaspular posterior catacts
Thrush
Eye (glaucoma, cataracts, increased P), Endo (DM)
Rage, raises BP
Osteopenia
Immunosuppresion
Dysphonia, DM

498
Q

ICS in asthma

A

does NOT prevent progressive loss lung function

499
Q

Binding affinity GC receptors

A

mometasone > fluticasone >budesonide > triamcinolone

500
Q

omalizumab indications

A

asthma >/6yo, evidence perennial aeroallergen
(no improved pulm function)

CU >/12

Nasal polyps >/18

Black box - anaphylaxis

501
Q

Mepolizumab

A

Asthma >6yo, eos >150

HES, EGPA, CRSwNP >18yo

Warning - herpes zoster

502
Q

Reslizumab

A

eos asthma >18 (eos >400)

IV only

Better in obese pts

Black box - anaphylaxis

503
Q

Bneralizumab

A

eos asthma >12yo (eos >300)

Kills eos/basos via ADCC

504
Q

TNF-a inhibitors

A

Infliximab, adalimumab, certolizab, golimumab

Block innate system

505
Q

Abatacept, belatacept

A

Blocks cd28 costimulation (b7-1, -2)
Bu

506
Q

Ruxolitinib

A

Jak1/2 inhibitor

507
Q

Tofacitinib

A

Jak 1/3 inhibitors
Used in RA, psoriatic arthritis, UC

508
Q

Baricitinib

A

Jak 1/2 inhibitor
Used in RA

509
Q

Methotrexate

A

Inhibits lymphocyte cell replication

510
Q

Azathioprine

A

Inhibits purine synthesis and metabolism

Causes apoptosis T cells, inhibits t and B cell proliferation

Urticarial vasculitis, chronic urticaria, glild

511
Q

MMF

A

Affects purine nt synthesis and metabolism

Decreased b and T cell proliferation, decreased Ab production
Used in chronic urticaria, organ transplant

512
Q

Cyclosporine

A

Inhibits Th function as calcineurin inhibitor, inhibits transcriptional factors (eg NFAT that is responsible for IL-2

513
Q

Tacrolimus

A

Inhibits txnal factors (eg nfat), inhibits T cell activation

Used in atopic derm >/2

514
Q

Rapamycin/sirolimus

A

Inhibits mTOR
Inhibits T cell activation, proliferation, Ab production

515
Q

Interferons

A

Interfere with viral infections

Type I - ifn a/b - antiviral
Type II - ifn-g - macrophage activating effects; used in CGD

Drugs - adverse effects flu like sx

516
Q

CAR-T cells

A

Chimeric antigen receptor
Have engineered receptors to recognize tumor cells

For B cell malignancies, (cml and all)

Some pts, car T cells become unresponsive over time
Increased T cell activation can also lead to cytokine release syndrome

517
Q

3 types gene therapy

A

1 - gene therapy/addition (introduce gene into cell)
2 - gene editing, site specific (crispr/
Cas9
3 - gene silencing (does not change gene sequencing)

518
Q

IGRT manufacturing method

A

Isolation- Modified Cohn-Oncley cold ethanol fractionation

519
Q

Dose IV igrt

A

0.3-0.6g/kg/mo
400-600mg/kg q3-4wks
For every 100mg increase —> 121mg increase in IgG trough

520
Q

SQ IGRT dose

A

100mg/kg/wk

521
Q

IG dose autoimmune

A

Higher dose - 2g/kg q3-4wks

522
Q

Epi dose

A

0.01 mg/kg of 1:1000 for SC/IM

0.01 mg/kg of 1:10,000 IV

523
Q

Polysaccharide vaccines

A

T indepen
Pneumovax (23-valent)
Meningococcal

524
Q

Conjugated

A

T-dependent
HiB, prevnar-13, meningococcal (menactra, menveo)

525
Q

In functional/anatomical asplenia vaccine recs

A

Separate pcv13 and menactra by at least 4 wks

526
Q

When to give ab-containing product after live vaccine administration

A

At least 2 wks

527
Q

Arthus reactions

A

Severe local reactions after vaccine administration due to high Ab titers
Most common after 4th/5th dose DTaP
Type iii hypersens - immune complex deposition

528
Q

Gelatin allergy vaccines

A

In Mmr, vzv, rabies, yellow fever

529
Q

Yeast is in which vaccines

A

HBV, HPV

530
Q

B cell ID vaccine ppx

A

Strep pneumonia
Flu
Menu gococcal
HPV

531
Q

T cell PID vaccine ppx

A

Live vaccines contraindicated
Likely ineffective otherwise in complete SCID, questionable in partial defects

532
Q

Contraindicated vaccines in phagocyte disorders

A

Love bacterial (can receive live viral)

533
Q

Steroid use and vaccines

A

If >20mg/d x2+wks -> wait 1 mo after stopping steroids

534
Q

Ivig and vaccine administration

A

If live vaccines given first > wait 2 wks for ivig

Ivig given first > wait 8+ months

535
Q

Indications typanostomy tubes

A

OME 3 episodes/6mo or 4/yr
Persistent OME x 3 mo (b/l) or 6 mo (unilateral)
Hearing loss

536
Q

Gell-Coombs classification

A

Type I - anaphylaxis (acute IgE-mediated; requires sensitization)
Type II - antibody depen cytotoxic rxns (cytopenias)
Type III - immune complex (eg serum sickness)
Type 4 - cell-mediated/delayed hypersens

537
Q

Subclassification type 4 gell-Coombs

A

IVa - th1 (ifn-g) - monocytes/macrophages - eczema, ppd
IVb - Th1 (IL-4, -5) - eos - maculopapular, DRESS
IVc - CTL (perforin and granzyme) - cd4/8 - bullous to pustular, increased cd8 in skin, SJS, fixed drug eruption
IVd - T cells and IL8 - involve PMNs - pustular rash - AGEP

538
Q

Prohapten hypothesis

A

Most drugs by themselves no immunogenic, only when metabolized to reactive metabolite

539
Q

P-I drug allergy concept

A

When drug binds to TCR with string enough affinity, esp when interacting with MHC, then may become immunogenic

540
Q

Atopy risk factor for what drug allergies

A

Latex, radiocontrast

541
Q

MHCs and assoc drug rxns

A

HLA-B*5701 - abacavir (test mutation before starting)

HLA-B*1502 - carbamazepine in Han Chinese (SJS/TEN)

HLA-A*3101 - carbamazepine in Europeans

HLA-B*5801 - allopurinol SCAR rxns in Asians

HLA-B*1301 - dapsone

542
Q

Drug induced hemolytic anemia

A

Quinidine, methyldooa, pcn

543
Q

Drug induced thrombocytopenia

A

Vanco, hep (HIT, IgG to hep-plat factor 4)
Sulfonamides, propulthiouracil, quinidine

544
Q

Serum sickness (like) rxns (type iii)
(Immune complexes)

A

Occurs 1-2wjs after first exposure or 1-7d in previously sensitized

With pcns, sulfonamides, phenytoin
Cefaclor most common cause kids

Fever, arthralgia, LAD, erythema multiforme/urticaria

545
Q

Arthus rxn (type iii)

A

Local selling and tenderness, maybe necrosis after vaccination
Typically with boosters
Onset w/in hours , resolves in days

546
Q

Al drug induced cutaneous lupus

A

Anti-ro (ssa) -La (ssb)
Hctz, CCB, ACE-I, antifungals

547
Q

SJS vs TEN

A

SJS <10% epidermal detachment
TEN >30% involvement

Steroids CONTRAINDICATED in TEN

Pcn, sulfonamides, anticonvulsants, nsaids, allopurinol

Fas/fasL mediated apoptosis epidermal cells, cd8 activation, perforin release

Ivig may help (some anti-Fas Ab)

548
Q

DRESS

A

Anticonvulsants, antimicrobiana, sulfonamides, allopurinol, minocycline

Fever, facial edema, LAD, hepatitis

Weeks after therapy and May worsen even after Tx d/c

549
Q

MRGPRX2

A

Mast cell receptor - certain drugs have this as a target, can cause pseudo allergic reactions (anaphylactoid)
Eg nmba, fluiroquinolones

550
Q

AGEP

A

Acute generalized exanthematous pustulosis

Pustular skin rash, fever, neutrophilia, eosinophilia

Onset 24hrs of drug

551
Q

Predictive value neg skin test to PCN major and minor determinants

A

97% rule out anaphylaxis potential

552
Q

Pcn major/minor determinants

A

Major - benzylpenicilloyl polylysine (pre-pen)

Minor - pen G, penicilloate

553
Q

Low risk pcn allergy

A

Mild Non IgE cutaneous sx,
IgE rxn >5 yrs ago
Unknown rxn

554
Q

Cephalosporin with unique r group

A

Cefazolin

555
Q

Major sulfonamide common reaction

A

Tmp/smx in pts with HIV - delayed maculopapular rash - T cell mediated

556
Q

Vanco reaction

A

VAncomycin May cause IgA bullous dermatitis

557
Q

Most common cause peri operative drug rxns

A

Quaternary ammonium muscle relaxants (succinylcholine)

558
Q

Bio marker cytokine release syndrome (drug rxn)

A

IL-6

559
Q

Contraindications desensitizations

A

Severe cutaneous reactions (eg blistering skin) immune complex mediated reactions
- ten/SJS, dress, serum sickness, hemolytic anemia, drug induced hepatitis/nephritis

560
Q

IgE levels for omalizumab

A

30-700

561
Q

Eerily and Kate phase mediators of SPT

A

Early - histamine, tryptase, chymase, carboxypeptidase, substance P, calcitonin gene related peptide (cgrp)

Late - cd4 T cell
Eos

562
Q

Intradermals most useful for

A

Pcn, chemo, muscle relaxants, insulin, heparin

563
Q

Most reproducible pft and primary outcome in most asthma drug trials

A

Fev1

564
Q

Factors affecting DLCO

A

Hgb levels
Increased with exercise, supine position, L-R cardiac shunt

Decreased by copd/emphysema, bronchiolitis obliterans, ild.
May be high in asthmatics

565
Q

Forced oscillation technique

A

Small P oscillations at mouth transmitted to lungs
Measures resistance and reactance
For those unable to cooperate with pft

566
Q

Significant response bronchodilator in adults

A

Increase FEV1 of 12% AND >/200ml

567
Q

Pft in emphysema

A

Decreased FEV1/FVC with decreased DLCO

568
Q

Methacholine challenge

A

Concentration of Methacholine that causes decrease in fev1 by 20% = PC20
PC20 of </ 8 is positive

Antimuscarinics and antichokinergics interfere with testing

569
Q

Mannitol v Methacholine

A

Methacholine with high sensitivity, rules out asthma

Mannitol with high specificity rules in asthma (particularly exercise induced)

570
Q

Factors that increase/decrease FeNO

A

Increase : asthma, atopy, Uris, >12yp, copd exacerbation, Eosinophilic bronchitis

Decrease: bronchiectasis, tobacco smoke, drugs (steroids, antileukotriene, NOS inhibitors), exercise, moderate altitude, hypothermia

571
Q

Ciliary structure

A

Filiar shaft contains fibrils composed of nine outer pairs of microtubules and 2 central microtubules
Adjacent doublets connected by dynein arms
Microtubules composed of tubulin

572
Q

Kartagener’a synd triad

A

CRS
Sitús inversus
Bronchiectasis

Auto R

Saccharine transit test shows slower mucociliary clearance/transit time

Bx preference is from
Carina

573
Q

Asthma sputum smear

A

Charcot Leyden crystals
Curschmamms spirals (corkscrew twists of condensed mucus)
Creola bodies (clumps sloughed epithelial cells)
ECO, MBP

574
Q

Eosinophils in eos asthma
Neutrophils in neutrophilic asthma

A

Eos >3%
Neutros > 76%

575
Q

Degree complement activation by Ig in descending order

A

IgM > IgG3 > IgG2 > IgG2

576
Q

Diagnostic feature ALPS

A

AlphaBeta double negative T cells
(Cd4-cd8-)

577
Q

Cd3- cells

A

B and NK cells

578
Q

Stem cell surface markers

A

Cd34+

579
Q

Treg surface markers

A

Cd3+ cd25+ foxp3+

580
Q

Naive nature B cell surface markers

A

Cd19+ surface IgM+ IgD+

581
Q

Mature B cell surface markers

A

Cd19+ cd21+

582
Q

Memory B cell surface markers

A

Cd19+ cd27+

583
Q

Nk vs NKT cell surface markers

A

NK: cd45+ cd2+ cd16+ cd56+

NKT: cd45+ cd3+ cd16+ cd56+

584
Q

Receptor in mature B cells that binds EBV and HHV8

A

CD21/cr2

also binds rhinovirus

585
Q

Adenovirus cell receptor

A

Cd46

586
Q

Rhinovirus receptor

A

Cd54

587
Q

CD59

A

Inhibits MAC in complement (binds c8, c9)

588
Q

LAD1 defect

A

Defect in common beta chain in CD18

589
Q

LAD2 defect

A

Defect in CD62E and P (NOT L)

590
Q

Inhibitory cell surface marker B cells

A

Cd22

591
Q

A4b7 in T cells bind what

A

MAdCAM-1 in gut

592
Q

Onalizumab binding site

A

CH3 domain on FREE IgE
At FCepsilonRI binding site

593
Q

Core rotors for HIV entry into cells

A

CCR5, CXCR4

594
Q

Prevnar vs pneumovax

A

Prevnar - conjugated polysaccharide, B and T cell

Pneumovax 23 - unconjugated polysaccharide, B cell only

595
Q

Cd56dim vs bright

A

Dim
- mature NK cells
- majority of NK cells, higher cytokinin activity

Bright
- immature NK cell

596
Q

Catalase + organisms

A

Staph aureus
Salmonella
Serrati
Pseudomonas

597
Q

Missing factors when ch50 low/ah50 nml

A

C1q/r/s, c4, c2

598
Q

Missing factors when ch50 nml /ah50 low

A

Factor B/D, properdin

599
Q

Missing factors when ch50 and ah50 absent

A

C3, c5-9

600
Q

Acquired vs hereditary complement deficiency

A

Hereditary - ch50/ah50 absent. Only one component missing

Acquired - levels low, not absent
Multiple components low

601
Q

How to test for infections in those with CVID, XLA, on IGRT

A

Ab testing unreliable
Use PCR

602
Q

Haller cell

A

Extension of ethmoid sinus and air cell
Along medial floor of orbit
Can increase risk acute rhinisinusitis

603
Q

Volumetric sampling methods

A

Impaction - most common; indoor/outdoor sampling
Impingement - liquid impingers draw air particles in; collect bioaerosols
Filtration - suck particles through a filter; detect dust, endotoxins, antigens, fungi, microorganisms

604
Q

Durham sampler

A

Gravitational sampler; simplest method
Slides coated w adhesive, exposed x 24h
Cheap, durable, no power source needed

Biased towards larger particles
Cannot determine air concentration (
Don’t know v of air)

605
Q

Settle plates

A

Sedimentation sampler
Particles settle on agar plate, then incubated and counted (bacteria, molds)
Identified viable airborn organisms
Indoor use only, biased larger particles, can’t determine airborn concentration

606
Q

Slit impactors

A

Burkhard - suction slit, for pollen and spores, frequently on rooftops, efficient for particles <10um, but need consistent wind speed, sampled from 24h-7d; expensive

Allergenico sampler - not wind-oriented, suction sampler collects on lab slides, primarily indoor use

607
Q

Rotating arm impactor

A

Rotorod - Rods sweep through air to collect particles on surfaces with adhesive tape,
Able to calculate air volume and concentration!
Not affected by wind
Not good for small particles (<10um) eg molds (they air stream around the rods)

608
Q

Sieve impactors

A

Anderson sieve impinger - series of sieves, air drawn in and passes through stages/sieves with progressively smaller holes, separated based in size
Used for culture based sampling fungi
Expensive

609
Q

Wind pollen sizes

A

20-60um

610
Q

Grass pollen

A

20-45um
Smooth surface with one pore

611
Q

Northern grasses

A

Timothy - Phl p 1-14
orchard
rye - Lol p 1-14
fescue
bluegrass - Poa p 1-14

612
Q

Southern grasses

A

Bermuda- cyn d 1-14
Bahia - Pas n 1, 13
Johnson - Sor h 1-14

613
Q

Ragweed

A

Amb a 1-10, profilin, cystatin

Spiny exine (outer surface),
15-25um

Pollen-food allergy with banana, cantaloupe, watermelon

614
Q

Mugwort/sage allergen

A

Art v 1-3, profilin

Smooth surface, tricolporate

OAS - celery spice, peach, mustard

Mugwort celery spice syndrome - celery, coriander, peppers, parsley, fennel

615
Q

Cockleburs

A

25-30um
Similar to ragweed with external spikes, but larger and smaller spines

616
Q

Nettle

A

One of smallest pollens
12-16um
Tri-tetraporate

Look wrinkled/air been sucked out of cell

617
Q

Plantain

A

20-40um
Many pores
Pore cap makes it look like doughnut

618
Q

Dock/sorrell

A

20-30um
Tricolporate
Starch inclusion granules - looks bubbly

619
Q

Ash pollen

A

Fra a 1
Furrows make square/pentagon appearance

620
Q

Birch

A

Bet v 1-7
Triporate
Looks like lemon when only 2 pores visible

Oas - Apple, apricot, carrot, celery, cherry, coriander, fennel, hazelnut, kiwi, nectarine, parsley, parsnip, pear, pepper, plum, peach, potato, walnut

621
Q

Birch OAS mneumonic

A

Pal, remember the ABC

Pear, peach, plum, potato
As well as apricot, apple
are linked to Birch
Along with Celery, cherry, And carrot

622
Q

Mountain cedar

A

Jun a 1-3

With cypress, juniper

Thick outer layer, granular inside, outer layer can break, look like PAC man

623
Q

Oak

A

Que a 1

Oak, beech, chestnut
Triangular, 3 white furrows slightly protruding from surface
25-35um

Oak - O with corners - triangle

624
Q

Syacamore

A

Pla a 1
Round, tricolpate, thin exine (outer covering)

625
Q

Pine

A

Mickey Mouse
Large - 50-100um

626
Q

Maple and box elder

A

Tricolpate
Look like beach balls with coloring

627
Q

Elm

A

4-7 oval shaped pores
Outer surface looks wavy

628
Q

Poplar, willow, cottonwood

A

Poplar/cottonwood - round, outer granular surface; no furrows

Willow - furrows

629
Q

Sweetgum

A

Soccer ball with many white pores

630
Q

Mulberry

A

Small 11-20um
2 pores,
Look like a lemon from the side (more granular than birch)

631
Q

Walnut hickory pecan

A

Walnut - Periporate - 9-15 pores

632
Q

Acacia pollen

A

Covered in nerf pads

633
Q

Alternaria

A

Club shaped
Dry day mold - in hay, grains

Alt a 1-12

634
Q

Cladosporium

A

Sausage chain, budding off
Delray day spore - inside and out
6-25um

Cla h 1-12

635
Q

Aspergillus

A

Indoor mold
Looks very similar to penicillin
Like dandelion puff

Asp f 1-22

636
Q

Penicillium

A

Paintbrush
Hypersens pneumonitis

Pen ch 13,18,20

637
Q

Helminthosporium, bipolaris

A

Single spores with thick walls
Look like worm
Allergic fungal sinusitis

638
Q

Epicoccum

A

Round multicell dry day spore
Dark brown, circular, warts on surface

639
Q

Fusarium

A

Colorless
Wet day spore
20-50um
Spindle shaped and curved with tapered ends - string bean

640
Q

Ascomycota

A

Lots of shapes and sizes
8 ascopores to an ascus

641
Q

Dry day mold spores - on dry, sunny, windy days

A

ACE
Alternaria
Cladosporidium
Epicoccum

642
Q

Molds at night and high humidity

A

Ascopores
Basidiospores

643
Q

Dust mite cross reacts with shrimp

A

Der p 10

644
Q

Group 1 dust mite allergens

A

Der p 1 and Der f 1
89% homology
Cysteine proteases

Der p/f2 - 80% homology
Lipopolysaccharise binding proteins

645
Q

Cockroach allergen

A

Bla g
Per a

646
Q

AQI values standardized for

A

Ozone, NO2, SO2, CO, PM

647
Q

AQI zones

A

0-50 - good
51-100 - mod
101-150 - unhealthy for sensitive groups
151-200 - unhealthy
201-300 - v unhealthy
301-500 - hazardous

648
Q

Nitrogen dioxide pollutant

A

Precursor to o3
Decreased in lung function, increased airway neutrophils, pro inflammatory cytokines
Allergen response at 0.4ppm

649
Q

Ozone pollutant

A

Peaks summer and in afternoon
In asthmatics, increases sx, hospitalizations, b agonist use
Decreased lung function acutely and chronically,
Increases neutrophils in airway, Il-6, Il-8, leukotrienes,
Increased airway reactivity and inflammation

Antioxidants (alpha-tocopherol, ascorbate) can help decrease ozone response, esp in gtsm1 def children

650
Q

So2 pollutant

A

Decreased lung function in children
Bronchospasm in asthmatics at 0.5ppm, reverses with beta agonists

651
Q

PM pollutant

A

Increased allergen sensitization
Airway inflammation
Asthma
CV disease
Strep pneumonia binding to airway epithelium

Pollutants activate innate immunity, increase TLRs and DAMPs -> inflammasome -> il-6, il-8

652
Q

Tobacco smoke

A

Assoc w recurrent OM, uri, lri, wheezing, cancer
Increases th2 and eos

653
Q

Allergens extracts with proteolytic activity

A

DM, cockroach, mold

Can’t mix mold/cockroach with pollens (DM ok with pollen)

654
Q

Dupilumab

A

eos asthma >6yo

AD >/6months. (can cause conjunctivitis)

CRSwNP > 18

EOE >12

655
Q

Catalase positive organisms
(CGD)

A

Staphylococcus aureus,
Serratia marsescens,
Burkholderia cepacia,
Nocardia,
Aspergillus.

656
Q

HAE ppx in pregnancy

A

pdC1-INH, subcutaneous

657
Q

Short term HAE ppx prior to sx

A

pdC1-INH, subcutaneous

658
Q

Epi dosing adults

A

0.3-0.5 of 1:1,000

659
Q
A
660
Q

Nemo part of which pathways

A

NF-KB
Ub of Nemo allows IKK-beta to become active —> P inhibitory component and allows NFkB to local size to nucleus

661
Q

Complement deficiency and macular degeneration

A

Factor H deficiency

662
Q

Stat4, stat6, stat3, stat5 involved with which t cells

A

TH1 – STAT3, Tbet
TH2 - STAT6, GATA3
TH17 - RORgT, STAT3
Tfh - BCL-6
Treg - STAT5

663
Q

Relative risk formula

A

Incidence among exposed/incidence unexposed
A/(a+b)
————
C/(c+d)

664
Q

Relative risk reduction formula

A

1-RR

(ARC-ART)/ARC